Exact Mass: 349.2828084

Exact Mass Matches: 349.2828084

Found 70 metabolites which its exact mass value is equals to given mass value 349.2828084, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

NAE 20:3

N-(11Z,14Z,17Z-eicosatrienoyl)-ethanolamine

C22H39NO2 (349.2980634)


   

Dihomo-gamma-linolenoylethanolamide

(8Z,11Z,14Z)-N-(2-Hydroxyethyl)icosa-8,11,14-trienamide

C22H39NO2 (349.2980634)


Dihomo-gamma-linolenoylethanolamide (DGLEA) is an N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation have been attributed to a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. During abstinence, young adults with a history of alcohol binge drinking had elevated plasma levels of monounsaturated and polyunsaturatedacylethanolamides, specifically oleoylethanolamide (OEA), palmitoleoylethanolamide (POEA), arachidonoylethanolamide (AEA), and dihomo-gamma-linolenoylethanolamide (DGLEA). Changes in these lipids positively correlated with mRNA upregulation of inflammatory markers in peripheral blood mononuclear cells (PBMCs), such as toll-like receptors (TLR4), pro-inflammatory cytokines/chemokines, and cyclooxygenase-2 (PMID: 29178411). Dihomo-gamma-Linolenoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249) [HMDB]

   

Abiraterone

2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-7,13-dien-5-ol

C24H31NO (349.2405516)


   

Dipipanone

4,4-diphenyl-6-(piperidin-1-yl)heptan-3-one

C24H31NO (349.2405516)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   
   
   
   

Mead acid ethanolamide

N-(2-hydroxyethyl)-5Z,8Z,11Z-eicosatrienamide

C22H39NO2 (349.2980634)


   
   
   
   

(2E,4E)-12-oxo-octadeca-2,4-dienoic acid isobutylamide

(2E,4E)-12-oxo-octadeca-2,4-dienoic acid isobutylamide

C22H39NO2 (349.2980634)


   
   

Oxime-(3alpha,5beta,20R)-3,20-Dihydroxypregnan-11-one

Oxime-(3alpha,5beta,20R)-3,20-Dihydroxypregnan-11-one

C21H35NO3 (349.26168000000007)


   

(4R*,4aS*,6R*,7S*,7aR*)-octahydro-2,4,7-trimethyl-1H-cyclopenta[c]pyridin-6-yl (2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dienoate|incarvine E

(4R*,4aS*,6R*,7S*,7aR*)-octahydro-2,4,7-trimethyl-1H-cyclopenta[c]pyridin-6-yl (2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dienoate|incarvine E

C21H35NO3 (349.26168000000007)


   
   

12-Oxo-2t-octadecensaeurepyrrolidid|2,3-Dehydrolycaonic acid pyrrolidide

12-Oxo-2t-octadecensaeurepyrrolidid|2,3-Dehydrolycaonic acid pyrrolidide

C22H39NO2 (349.2980634)


   

Arachidonoyl-2-Fluoroethylamide

Arachidonoyl-2-Fluoroethylamide

C22H36FNO (349.2780778)


   

Abiraterone

Abiraterone (CB-7598)

C24H31NO (349.2405516)


A 3beta-sterol that is androsta-5,16-dien-3beta-ol substituted at position 17 by a 3-pyridyl group. Administered as the O-acetate, it is used for treatment of metastatic castrate-resistant prostate cancer. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C471 - Enzyme Inhibitor > C147923 - CYP17A1 Inhibitor

   

dipipanone

dipipanone

C24H31NO (349.2405516)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

2-fluoro Anandamide

N-(2-fluro-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C22H36FNO (349.2780778)


   

Anandamide (20:3, n-3)

N-(11Z,14Z,17Z-eicosatrienoyl)-ethanolamine

C22H39NO2 (349.2980634)


   

JWH018 adamantyl

1-pentyl-3-(1-adamantoyl)indole

C24H31NO (349.2405516)


   
   
   

arachidonoyl-(2-fluoroethyl)amide

N-(2-fluoro-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C22H36NOF (349.2780778)


   

N,N-Dimethyl-N-octyl-1-octanaminium bromide

N,N-Dimethyl-N-octyl-1-octanaminium bromide

C18H40BrN (349.23439400000007)


   

3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[tris(propan-2-yl)silyl]-1H-pyrrole

3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[tris(propan-2-yl)silyl]-1H-pyrrole

C19H36BNO2Si (349.2608226)


   

Aluminum magnesium isopropoxide

Aluminum magnesium isopropoxide

C15H38AlMgO5 (349.2385008)


   

1-octadecylpyrrole-2,5-dione

1-octadecylpyrrole-2,5-dione

C22H39NO2 (349.2980634)


   

1-[Decanoyl(methyl)amino]-1-deoxy-D-glucitol

1-[Decanoyl(methyl)amino]-1-deoxy-D-glucitol

C17H35NO6 (349.24642500000004)


   

9,9-dihexyl-2-Amino-9H-fluorene

9,9-dihexyl-2-Amino-9H-fluorene

C25H35N (349.27693500000004)


   
   

3-Pinacolateboryl-1H-pyrrole

3-Pinacolateboryl-1H-pyrrole

C19H36BNO2Si (349.2608226)


   

Sodium N-tetradecanoyl-L-valinate

Sodium N-tetradecanoyl-L-valinate

C19H36NNaO3 (349.2592746)


   

Sodium N-hexadecanoyl-L-alaninate

Sodium N-hexadecanoyl-L-alaninate

C19H36NNaO3 (349.2592746)


   
   

sodium N-methyl-N-(1-oxohexadecyl)aminoacetate

sodium N-methyl-N-(1-oxohexadecyl)aminoacetate

C19H36NNaO3 (349.2592746)


   

Tetradecyldimethylethylammonium bromide

Tetradecyldimethylethylammonium bromide

C18H40BrN (349.23439400000007)


   
   

N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide

N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide

C21H35NO3 (349.26168000000007)


   

1-Azabicyclo[2.2.2]octan-3-yl-bis(3,4-dimethylphenyl)methanol

1-Azabicyclo[2.2.2]octan-3-yl-bis(3,4-dimethylphenyl)methanol

C24H31NO (349.2405516)


   
   

(8E,11E,14E)-N-(2-hydroxyethyl)icosa-8,11,14-trienamide

(8E,11E,14E)-N-(2-hydroxyethyl)icosa-8,11,14-trienamide

C22H39NO2 (349.2980634)


   

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.23652960000004)


   

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.23652960000004)


   

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.23652960000004)


   

(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.23652960000004)


   

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.23652960000004)


   

(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.23652960000004)


   

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.23652960000004)


   

(2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.23652960000004)


   

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.23652960000004)


   

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.23652960000004)


   

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.23652960000004)


   

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.23652960000004)


   

(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.23652960000004)


   

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.23652960000004)


   

(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.23652960000004)


   

(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.23652960000004)


   

(3S,8R,9R,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8R,9R,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

C24H31NO (349.2405516)


   

N-(5Z,8Z,11Z-eicosatrienoyl)-ethanolamine

N-(5Z,8Z,11Z-eicosatrienoyl)-ethanolamine

C22H39NO2 (349.2980634)


   

N-cis-11, 14,17-eicosatrienoylethanolamine

N-cis-11, 14,17-eicosatrienoylethanolamine

C22H39NO2 (349.2980634)


   
   
   
   
   

11Z,14Z,17Z-Eicosatrienoyl-EA

11Z,14Z,17Z-Eicosatrienoyl-EA

C22H39NO2 (349.2980634)